The BioTalent Advisory Board brings together senior leaders from across biotech, pharma services, MedTech and life sciences investment, combining diverse expertise and perspectives from across the industry. The Board provides strategic insight across our three solutions, BioTalent, BioX and Talent Science™, helping to inform product direction, commercial positioning and Go-to-Market strategy through real-world buyer and industry perspectives.
It also creates a forum for open discussion around the forces shaping talent and the future of life sciences. From capital markets and M&A activity to regulatory change and evolving workforce needs, the Board helps us stay closely connected to the challenges, opportunities and priorities facing the industry. By bringing these perspectives together, we can continue to evolve our solutions around what life sciences organisations and their people need, both today and in the future.
Learn more about the senior leaders spanning biotech, pharma services, MedTech and life sciences investment that make up our Advisory Board.
BioTalent launches Advisory Board to shape the future of life sciences talent
INSIGHT
[LONDON — 1 October 2026] BioTalent, the specialist life sciences talent consultancy and part of The IN Group, has launched an Advisory Board, bringing together senior leaders from across biotech, pharma services, MedTech and life sciences investment.
The Board will advise BioTalent across its three product lines — BioTalent, BioX and Talent Science™ — on product direction, commercial positioning and go-to-market strategy, informed directly by buyer and industry perspective. It will also serve as a peer forum on the wider forces shaping talent in life sciences, from capital markets and M&A activity to regulatory shifts and the changing shape of the workforce.
Members will meet three times a year, with the inaugural meeting held in Basel on 1 October 2026.
"Launching our first Advisory Board is a defining moment for BioTalent. Life sciences is being reshaped by AI, new modalities and a fundamental shift in how organisations find, build and deploy talent. To serve our clients well through that change, we need to be challenged by people who see the industry from every angle. That is exactly what this Board brings. We have brought together exceptional leaders spanning board executives, C suite, investors and HR. Their breadth of perspective will sharpen how we develop and bring to market our three product lines: Talent Science, BioX and BioTalent. Just as importantly, the Board creates a forum for candid, peer level exchange on the trends shaping our industry. I am grateful to each of our advisors for committing their time and insight, and I look forward to building the next chapter of BioTalent together."
— James Cox, CEO & Founder, BioTalent
“James Cox and I [saw] the value of having a cross-industry advisory board with senior thought leader representation from the key stakeholder groups. Having chaired previous Global Advisory Boards and seen the unique and high valuable insights into both the current thinking within the sector and the problems faced and solutions needed, I was delighted to be invited to chair this Board."
— David Holloway, Board Executive & Chair, Independent
“What appeals to me about the Advisory Board is the exchange, not advice alone. The diversity of backgrounds around the table, from operators and talent leaders to investors and technology entrepreneurs, reflects the breadth of challenges facing life sciences today. I look forward to candid dialogue that brings different perspectives together and turns them into more useful questions, and hopefully better choices, for the industry.”
— Thorsten Hein, CEO, Bayer (Schweiz) AG
BioTalent is a specialist talent consultancy for the life sciences industry, delivering flexible hiring solutions built around each client's workforce strategy. BioTalent works with organisations across biotechnology, pharmaceuticals, MedTech, diagnostics, pharma services, instrumentation and TechBio, drawing on a database of 2m+ qualified candidates and a community network of over 650k professionals. The company holds a Net Promoter Score of 76, which is considered world-class by industry benchmarks.
BioX, its executive search arm, secures the leadership that shapes a company's trajectory, from C-suite and board appointments through to fractional and interim executives. Talent Science™, BioTalent's workforce intelligence solution, is the first quantitative and predictive workforce modelling platform designed specifically for life sciences, giving organisations the quantitative insight to know exactly who they need before they start hiring.
With a team spanning the UK, US, EMEA and APAC, BioTalent sits at the epicentre of global life sciences, supporting life sciences businesses globally.
BioTalent is part of The IN Group, a collection of six talent brands that cover talent advisory, transformation, managed services, executive search and staffing.
Alice Hankin
Marketing Manager at The IN Group
alice.hankin@wearetig.com